NeOnc Technologies Holdings Inc.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol NTHI:xnas
Currency USD
NASDAQ
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (“FDA”).
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.191016416bn
Data Provided by 
/ 
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.